POLYDEX PHARMACEUT COM USD0.0167 (POLXF)

1.25
0.03 2.46
OTC
Prev Close 1.22
Open 1.25
Day Low/High 1.25 / 1.25
52 Wk Low/High 0.85 / 2.82
Volume 500.00
Exchange OTC
Shares Outstanding 3.07B
Market Cap 3.75M
Div & Yield N.A. (N.A)

Polydex Pharmaceuticals Issues First Quarter Financial Results

More Than Three Years of Sustained Profitability Despite Impact of Currency Exchange

Polydex Reports Second Quarter Financial Results

32% Increase in Sales Leads to 150% Increase in Gross Profit

Polydex Pharmaceuticals Issues First Quarter Financial Results

329% Increase in Profit Over Last Year's First Quarter

Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results

Strong Fundamentals Result in Sustained Profitability

Polydex Pharmaceuticals Issues First Quarter Financial Results

Profitability Remains a Priority While Facility Upgrades Planned

Polydex Pharmaceuticals Provides Year End Financial Report Showing Sales Up 14.8% And Margins Increased To 24%

Product Demand Drives EBITDA to a Gain of $837,645 From a Loss of $200,463

Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results

Profitability Continues for Third Straight Quarter

Polydex Pharmaceuticals Issues First Quarter Financial Results

Sales and Profit Margins Up Resulting in Return to Profitability

Polydex Pharmaceuticals Ltd. Reports 3rd Quarter Financial Results

High Demand for Product Temporarily Strains Production Equipment, Getting Back on Track

Wednesday's Small-Cap Winners & Losers

Levitt shares surge on a $286 million buyout offer.